Meeting
2013 ASCO Annual Meeting
Impact of delaying initiation of adjuvant chemotherapy in breast cancer patients.
Authors
Debora De Melo Gagliato
The University of Texas MD Anderson Cancer Center, Houston, TX
Debora De Melo Gagliato , Ana M. Gonzalez-Angulo , Xiudong Lei , Sharon Hermes Giordano , Richard L. Theriault , Vicente Valero , Gabriel N. Hortobagyi , Mariana Chavez-Mac Gregor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 31, 2013 (suppl; abstr 1022)
DOI
10.1200/jco.2013.31.15_suppl.1022
Abstract #
1022
Poster Bd #
14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
Clinical profiles and outcomes of patients enrolled in the Department of Health: Breast Cancer Medicines Access Program in the Philippines—A single center experience.
First Author: Jason King Dalusung Talao
Poster
2013 Gastrointestinal Cancers Symposium
Reasons for delay in time to initiation of adjuvant chemotherapy (AC) for colon cancer (CC).
First Author: David Wasserman
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Real-world impact of initial treatment modality on survival outcomes in patients with stage I-III pancreatic ductal adenocarcinoma.
First Author: Ajay Prakash
Poster
2022 ASCO Annual Meeting
Impact of the COVID-19 pandemic on stage at diagnosis of patients with breast cancer: An analysis of 11,752 patients from Oncoclínicas.
First Author: Cristiano Augusto Andrade de Resende